Header Image
News Room / Biotechnology


RSS Feed

Rosetta Genomics Granted European Patent Allowance Covering RosettaGX Cancer Origin Assay
5/25/2017 -- 8:30 AM -- Rosetta Genomics Ltd.

MorphoSys Announces That Its Licensee Janssen Reported Updates on the Development of Guselkumab
5/24/2017 -- 6:10 AM -- MorphoSys AG

MorphoSys to Present at Three Upcoming Conferences
5/24/2017 -- 2:00 AM -- MorphoSys AG

Rosetta Genomics Enters Collaboration to Develop a microRNA Classifier Relating to Patients with Non-Small Cell Lung Cancer Considered for Treatment with Immuno-oncology Drugs
5/23/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

Rosetta Genomics Focusing Efforts on Improving Cash Position through Sale of the PersonalizeDx Business and Monetizing IP
5/22/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

MorphoSys Announces First Results from Phase 1 Study with Lanthipeptide MOR107 in Healthy Volunteers
5/19/2017 -- 2:00 AM -- MorphoSys AG

American Cryostem Retains Target Health To Initiate FDA Drug Master Files And 510K Approvals
5/18/2017 -- 8:00 AM -- American CryoStem Corporation

MorphoSys to Present Clinical Data on Proprietary Programs at Upcoming ASCO Annual Meeting 2017
5/18/2017 -- 2:00 AM -- MorphoSys AG

MorphoSys AG Reports Outcome of Annual General Meeting 2017
5/17/2017 -- 9:00 AM -- MorphoSys AG

Rosetta Genomics Announces Favorable Results from Two Pilot Studies Comparing RosettaGX Reveal(TM) and the Afirma GEC Assay for the Classification of Indeterminate Thyroid Nodules
5/12/2017 -- 9:23 AM -- Rosetta Genomics Ltd.

BacTech Reports Consistent High Grades From Telamayu Drilling
5/8/2017 -- 1:45 PM -- BacTech Environmental Corporation

Cultivation Technologies, Inc. Launches Genetic Improvement Program for Medical Cannabis; Led by Two Biotech Experts with 70 Years Combined Experience
5/8/2017 -- 6:00 AM -- Cultivation Technologies, Inc.

CYIG Purchases a New Business that Will Increase Sales of a Billion U.S. Dollars for the Company in Next 5 Years
5/5/2017 -- 10:00 AM -- China YCT International Group, Inc.

Rosetta Genomics Expands International Access for RosettaGX Reveal(TM) through Agreement with Cytolog Laboratories in Brazil
5/5/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

Rosetta Genomics Receives Final Approval from New York State for First-of-its-kind Thyroid Cancer Diagnostic Assay
5/4/2017 -- 9:00 AM -- Rosetta Genomics Ltd.

Abattis Announces the Official Launch of Northern Vine Laboratory
5/3/2017 -- 9:30 AM -- Abattis Bioceuticals Corp.

Rosetta Genomics to Increase Investment in RosettaGX Reveal(TM) and Explore Strategic Alternatives for the PersonalizeDx Business
5/2/2017 -- 9:00 AM -- Rosetta Genomics Ltd.

Rosetta Genomics Expands Patent Portfolio in Europe and Japan
5/1/2017 -- 8:30 AM -- Rosetta Genomics Ltd.